| ChemBridge Corporation | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (858) 451-7400 | |||
![]() |
sales@chembridge.com | |||
| Chemical manufacturer | ||||
| Fluorochem Ltd. | UK | Inquire | ||
|---|---|---|---|---|
![]() |
+44 (1457) 860-111 | |||
![]() |
enquiries@fluorochem.co.uk | |||
| Chemical manufacturer | ||||
| International Laboratory Limited | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (650) 278-9963 | |||
![]() |
admin@intlab.org | |||
| Chemical manufacturer since 2002 | ||||
| Matrix Scientific Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (803) 788-9494 | |||
![]() |
sales@matrixscientific.com | |||
| Chemical manufacturer | ||||
| SynQuest Labs, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (386) 462-0788 | |||
![]() |
info@synquestlabs.com | |||
| Chemical manufacturer | ||||
| TimTec | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (302) 292-8500 | |||
![]() |
info@timtec.com | |||
| Chemical manufacturer | ||||
| Zylexa Pharma Ltd. | UK | Inquire | ||
|---|---|---|---|---|
![]() |
+44 (845) 299-6009/ | |||
![]() |
sales@zylexa-pharma.com,enquiries@zylexa-pharma.com | |||
| Chemical manufacturer | ||||
| Name | 3-Bromo-2-(Trifluoromethyl)Imidazo[1,2-a]Pyridine |
|---|---|
| Synonyms | 3-bromo-2-(trifluoromethyl)-4-hydroimidazo[1,2-a]pyridine; 3-Bromo-2-(trifluoromethyl)imidazo[1,2-a]pyridine; MFCD11111688 |
| Molecular Structure | ![]() |
| Molecular Formula | C8H4BrF3N2 |
| Molecular Weight | 265.03 |
| CAS Registry Number | 503172-42-7 |
| SMILES | c1ccn2c(c1)nc(c2Br)C(F)(F)F |
| InChI | 1S/C8H4BrF3N2/c9-7-6(8(10,11)12)13-5-3-1-2-4-14(5)7/h1-4H |
| InChIKey | UWFXWNIDZUWCAY-UHFFFAOYSA-N |
| Density | 1.809g/cm3 (Cal.) |
|---|---|
| Melting point | 98-100°C (Expl.) |
| Refractive index | 1.584 (Cal.) |
| Safety Description | Irritant/Light Sensitive |
|---|---|
| R36/37/38 | |
| IRRITANT | |
| S24/25,S36/37/39,S45 | |
| SDS | Available |
| Market Analysis Reports |
| List of Reports Available for 3-Bromo-2-(Trifluoromethyl)Imidazo[1,2-a]Pyridine |